PMC:7205724 / 1428-1677 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"51","span":{"begin":82,"end":85},"obj":"Gene"},{"id":"52","span":{"begin":139,"end":142},"obj":"Gene"},{"id":"60","span":{"begin":15,"end":23},"obj":"Species"},{"id":"61","span":{"begin":120,"end":128},"obj":"Species"},{"id":"62","span":{"begin":183,"end":192},"obj":"Species"},{"id":"64","span":{"begin":39,"end":50},"obj":"Chemical"},{"id":"76","span":{"begin":29,"end":37},"obj":"Disease"}],"attributes":[{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"Gene:3569"},{"id":"A52","pred":"tao:has_database_id","subj":"52","obj":"Gene:3569"},{"id":"A60","pred":"tao:has_database_id","subj":"60","obj":"Tax:9606"},{"id":"A61","pred":"tao:has_database_id","subj":"61","obj":"Tax:9606"},{"id":"A62","pred":"tao:has_database_id","subj":"62","obj":"Tax:2697049"},{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"MESH:C502936"},{"id":"A76","pred":"tao:has_database_id","subj":"76","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"d prognosis of patients with COVID-19. Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels. Essential elements that process SARS-CoV2 cell entry and specific characteristics that allow SARS-"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T5","span":{"begin":65,"end":73},"obj":"Body_part"},{"id":"T6","span":{"begin":193,"end":197},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"d prognosis of patients with COVID-19. Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels. Essential elements that process SARS-CoV2 cell entry and specific characteristics that allow SARS-"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T17","span":{"begin":29,"end":37},"obj":"Disease"},{"id":"T18","span":{"begin":183,"end":187},"obj":"Disease"},{"id":"T19","span":{"begin":244,"end":248},"obj":"Disease"}],"attributes":[{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"d prognosis of patients with COVID-19. Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels. Essential elements that process SARS-CoV2 cell entry and specific characteristics that allow SARS-"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T5","span":{"begin":52,"end":53},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T6","span":{"begin":193,"end":197},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"d prognosis of patients with COVID-19. Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels. Essential elements that process SARS-CoV2 cell entry and specific characteristics that allow SARS-"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T3","span":{"begin":193,"end":197},"obj":"http://purl.obolibrary.org/obo/CL_0000000"}],"text":"d prognosis of patients with COVID-19. Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels. Essential elements that process SARS-CoV2 cell entry and specific characteristics that allow SARS-"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T17","span":{"begin":29,"end":37},"obj":"Species"},{"id":"T18","span":{"begin":183,"end":192},"obj":"Species"}],"attributes":[{"id":"A17","pred":"ncbi_taxonomy_id","subj":"T17","obj":"NCBItxid:2697049"},{"id":"A18","pred":"ncbi_taxonomy_id","subj":"T18","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"d prognosis of patients with COVID-19. Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels. Essential elements that process SARS-CoV2 cell entry and specific characteristics that allow SARS-"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T19","span":{"begin":39,"end":150},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"d prognosis of patients with COVID-19. Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels. Essential elements that process SARS-CoV2 cell entry and specific characteristics that allow SARS-"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"60","span":{"begin":15,"end":23},"obj":"Species"},{"id":"76","span":{"begin":29,"end":37},"obj":"Disease"},{"id":"64","span":{"begin":39,"end":50},"obj":"Chemical"},{"id":"51","span":{"begin":82,"end":85},"obj":"Gene"},{"id":"61","span":{"begin":120,"end":128},"obj":"Species"},{"id":"52","span":{"begin":139,"end":142},"obj":"Gene"},{"id":"62","span":{"begin":183,"end":192},"obj":"Species"}],"attributes":[{"id":"A60","pred":"pubann:denotes","subj":"60","obj":"Tax:9606"},{"id":"A76","pred":"pubann:denotes","subj":"76","obj":"MESH:C000657245"},{"id":"A64","pred":"pubann:denotes","subj":"64","obj":"MESH:C502936"},{"id":"A51","pred":"pubann:denotes","subj":"51","obj":"Gene:3569"},{"id":"A61","pred":"pubann:denotes","subj":"61","obj":"Tax:9606"},{"id":"A52","pred":"pubann:denotes","subj":"52","obj":"Gene:3569"},{"id":"A62","pred":"pubann:denotes","subj":"62","obj":"Tax:2697049"}],"text":"d prognosis of patients with COVID-19. Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels. Essential elements that process SARS-CoV2 cell entry and specific characteristics that allow SARS-"}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T177","span":{"begin":82,"end":85},"obj":"Protein"},{"id":"T221","span":{"begin":139,"end":142},"obj":"Protein"}],"attributes":[{"id":"A177","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q9XT80"},{"id":"A178","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q9UCU4"},{"id":"A179","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q9UCU3"},{"id":"A180","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q9UCU2"},{"id":"A181","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q9MZR1"},{"id":"A182","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q9MYZ7"},{"id":"A183","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q95KN6"},{"id":"A184","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q95181"},{"id":"A185","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q90YI0"},{"id":"A186","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q8MKH0"},{"id":"A187","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q8BN26"},{"id":"A188","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q865X6"},{"id":"A189","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q865W7"},{"id":"A190","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q6V919"},{"id":"A191","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q6L6X6"},{"id":"A192","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q5I6E3"},{"id":"A193","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q3UCQ0"},{"id":"A194","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q2MH06"},{"id":"A195","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q28819"},{"id":"A196","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q28747"},{"id":"A197","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q28319"},{"id":"A198","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q25BC2"},{"id":"A199","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q0PW36"},{"id":"A200","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q0GGL7"},{"id":"A201","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/Q08DT2"},{"id":"A202","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/P79341"},{"id":"A203","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/P51494"},{"id":"A204","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/P46650"},{"id":"A205","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/P41693"},{"id":"A206","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/P41683"},{"id":"A207","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/P41323"},{"id":"A208","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/P29455"},{"id":"A209","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/P26893"},{"id":"A210","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/P26892"},{"id":"A211","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/P20607"},{"id":"A212","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/P08505"},{"id":"A213","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/P05231"},{"id":"A214","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/O46568"},{"id":"A215","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/O35736"},{"id":"A216","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/O19007"},{"id":"A217","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/B6CKP4"},{"id":"A218","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/A9QWQ9"},{"id":"A219","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/A3FBE9"},{"id":"A220","pred":"uniprot_id","subj":"T177","obj":"https://www.uniprot.org/uniprot/A0S0B0"},{"id":"A221","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q9XT80"},{"id":"A222","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q9UCU4"},{"id":"A223","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q9UCU3"},{"id":"A224","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q9UCU2"},{"id":"A225","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q9MZR1"},{"id":"A226","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q9MYZ7"},{"id":"A227","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q95KN6"},{"id":"A228","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q95181"},{"id":"A229","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q90YI0"},{"id":"A230","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q8MKH0"},{"id":"A231","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q8BN26"},{"id":"A232","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q865X6"},{"id":"A233","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q865W7"},{"id":"A234","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q6V919"},{"id":"A235","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q6L6X6"},{"id":"A236","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q5I6E3"},{"id":"A237","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q3UCQ0"},{"id":"A238","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q2MH06"},{"id":"A239","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q28819"},{"id":"A240","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q28747"},{"id":"A241","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q28319"},{"id":"A242","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q25BC2"},{"id":"A243","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q0PW36"},{"id":"A244","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q0GGL7"},{"id":"A245","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/Q08DT2"},{"id":"A246","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/P79341"},{"id":"A247","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/P51494"},{"id":"A248","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/P46650"},{"id":"A249","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/P41693"},{"id":"A250","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/P41683"},{"id":"A251","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/P41323"},{"id":"A252","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/P29455"},{"id":"A253","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/P26893"},{"id":"A254","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/P26892"},{"id":"A255","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/P20607"},{"id":"A256","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/P08505"},{"id":"A257","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/P05231"},{"id":"A258","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/O46568"},{"id":"A259","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/O35736"},{"id":"A260","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/O19007"},{"id":"A261","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/B6CKP4"},{"id":"A262","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/A9QWQ9"},{"id":"A263","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/A3FBE9"},{"id":"A264","pred":"uniprot_id","subj":"T221","obj":"https://www.uniprot.org/uniprot/A0S0B0"}],"text":"d prognosis of patients with COVID-19. Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels. Essential elements that process SARS-CoV2 cell entry and specific characteristics that allow SARS-"}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T217","span":{"begin":2,"end":11},"obj":"NN"},{"id":"T218","span":{"begin":12,"end":14},"obj":"IN"},{"id":"T219","span":{"begin":15,"end":23},"obj":"NNS"},{"id":"T220","span":{"begin":24,"end":28},"obj":"IN"},{"id":"T221","span":{"begin":29,"end":37},"obj":"NN"},{"id":"T222","span":{"begin":39,"end":50},"obj":"NNP"},{"id":"T223","span":{"begin":50,"end":51},"obj":"-COMMA-"},{"id":"T224","span":{"begin":52,"end":53},"obj":"DT"},{"id":"T225","span":{"begin":54,"end":64},"obj":"JJ"},{"id":"T226","span":{"begin":65,"end":73},"obj":"NN"},{"id":"T227","span":{"begin":74,"end":81},"obj":"IN"},{"id":"T228","span":{"begin":82,"end":85},"obj":"NN"},{"id":"T229","span":{"begin":85,"end":86},"obj":"-COMMA-"},{"id":"T230","span":{"begin":87,"end":92},"obj":"MD"},{"id":"T231","span":{"begin":93,"end":99},"obj":"VB"},{"id":"T232","span":{"begin":100,"end":108},"obj":"JJ"},{"id":"T233","span":{"begin":109,"end":116},"obj":"NN"},{"id":"T234","span":{"begin":117,"end":119},"obj":"IN"},{"id":"T235","span":{"begin":120,"end":128},"obj":"NNS"},{"id":"T236","span":{"begin":129,"end":133},"obj":"IN"},{"id":"T237","span":{"begin":134,"end":138},"obj":"JJ"},{"id":"T238","span":{"begin":139,"end":142},"obj":"NN"},{"id":"T239","span":{"begin":143,"end":149},"obj":"NNS"},{"id":"T240","span":{"begin":151,"end":160},"obj":"JJ"},{"id":"T241","span":{"begin":161,"end":169},"obj":"NNS"},{"id":"T242","span":{"begin":170,"end":174},"obj":"IN"},{"id":"T243","span":{"begin":175,"end":182},"obj":"NN"},{"id":"T244","span":{"begin":183,"end":192},"obj":"NN"},{"id":"T245","span":{"begin":193,"end":197},"obj":"NN"},{"id":"T246","span":{"begin":198,"end":203},"obj":"NN"},{"id":"T247","span":{"begin":204,"end":207},"obj":"CC"},{"id":"T248","span":{"begin":208,"end":216},"obj":"JJ"},{"id":"T249","span":{"begin":217,"end":232},"obj":"NNS"},{"id":"T250","span":{"begin":233,"end":237},"obj":"WDT"},{"id":"T251","span":{"begin":238,"end":243},"obj":"VBP"}],"relations":[{"id":"R209","pred":"arg1Of","subj":"T217","obj":"T218"},{"id":"R210","pred":"arg2Of","subj":"T219","obj":"T218"},{"id":"R211","pred":"arg1Of","subj":"T219","obj":"T220"},{"id":"R212","pred":"arg2Of","subj":"T221","obj":"T220"},{"id":"R213","pred":"arg1Of","subj":"T222","obj":"T223"},{"id":"R214","pred":"arg2Of","subj":"T226","obj":"T223"},{"id":"R215","pred":"arg1Of","subj":"T226","obj":"T224"},{"id":"R216","pred":"arg1Of","subj":"T226","obj":"T225"},{"id":"R217","pred":"arg1Of","subj":"T226","obj":"T227"},{"id":"R218","pred":"arg2Of","subj":"T228","obj":"T227"},{"id":"R219","pred":"arg1Of","subj":"T231","obj":"T229"},{"id":"R220","pred":"arg1Of","subj":"T222","obj":"T230"},{"id":"R221","pred":"arg2Of","subj":"T231","obj":"T230"},{"id":"R222","pred":"arg1Of","subj":"T222","obj":"T231"},{"id":"R223","pred":"arg2Of","subj":"T233","obj":"T231"},{"id":"R224","pred":"arg1Of","subj":"T233","obj":"T232"},{"id":"R225","pred":"arg1Of","subj":"T231","obj":"T234"},{"id":"R226","pred":"arg2Of","subj":"T235","obj":"T234"},{"id":"R227","pred":"arg1Of","subj":"T235","obj":"T236"},{"id":"R228","pred":"arg2Of","subj":"T239","obj":"T236"},{"id":"R229","pred":"arg1Of","subj":"T239","obj":"T237"},{"id":"R230","pred":"arg1Of","subj":"T239","obj":"T238"},{"id":"R231","pred":"arg1Of","subj":"T241","obj":"T240"},{"id":"R232","pred":"arg1Of","subj":"T241","obj":"T242"},{"id":"R233","pred":"arg2Of","subj":"T247","obj":"T242"},{"id":"R235","pred":"arg1Of","subj":"T246","obj":"T243"},{"id":"R236","pred":"arg1Of","subj":"T246","obj":"T244"},{"id":"R237","pred":"arg1Of","subj":"T246","obj":"T245"},{"id":"R238","pred":"arg1Of","subj":"T246","obj":"T247"},{"id":"R239","pred":"arg2Of","subj":"T249","obj":"T247"},{"id":"R240","pred":"arg1Of","subj":"T249","obj":"T248"},{"id":"R241","pred":"arg1Of","subj":"T249","obj":"T250"},{"id":"R242","pred":"arg1Of","subj":"T249","obj":"T251"}],"text":"d prognosis of patients with COVID-19. Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels. Essential elements that process SARS-CoV2 cell entry and specific characteristics that allow SARS-"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T5","span":{"begin":65,"end":73},"obj":"Body_part"},{"id":"T6","span":{"begin":193,"end":197},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"d prognosis of patients with COVID-19. Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels. Essential elements that process SARS-CoV2 cell entry and specific characteristics that allow SARS-"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T17","span":{"begin":29,"end":37},"obj":"Disease"},{"id":"T18","span":{"begin":183,"end":192},"obj":"Disease"}],"attributes":[{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"d prognosis of patients with COVID-19. Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels. Essential elements that process SARS-CoV2 cell entry and specific characteristics that allow SARS-"}

{"project":"LitCovid-sentences","denotations":[{"id":"T19","span":{"begin":39,"end":150},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"d prognosis of patients with COVID-19. Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels. Essential elements that process SARS-CoV2 cell entry and specific characteristics that allow SARS-"}